Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Earnings Calls In Brief

This article was originally published in The Gray Sheet

Executive Summary

J&J/DePuy orthopedic sales: Firm reports hip sales increase of 12% in the third quarter, while knee revenue was up 9% for the period, contributing to overall DePuy revenue of $1.09 billion for the three months - an 11.9% advance from last year, the firm reported Oct. 16. Growth in the segment contributed to parent firm Johnson & Johnson's 6% overall increase in device sales for the quarter - to $5.2 billion

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025420

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel